Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trialsThe Lancet (British edition), 2022-11, Vol.400 (10365), p.1788-1801 [Peer Reviewed Journal]2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02074-8 ;PMID: 36351458Full text available |
|
2 |
Material Type: Article
|
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsThe Lancet (British edition), 2019-01, Vol.393 (10166), p.31-39 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32590-X ;PMID: 30424892Full text available |
|
3 |
Material Type: Article
|
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2015-01, Vol.385 (9965), p.341-350 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 24, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61374-X ;PMID: 25282520 ;CODEN: LANCAOFull text available |
|
4 |
Material Type: Article
|
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular EventsThe New England journal of medicine, 2015-04, Vol.372 (16), p.1500-1509 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1500858 ;PMID: 25773607Full text available |
|
5 |
Material Type: Article
|
Clinical evidence for oral antiplatelet therapy in acute coronary syndromesThe Lancet (British edition), 2015-07, Vol.386 (9990), p.292-302 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 18, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)60213-6 ;PMID: 25777663 ;CODEN: LANCAOFull text available |
|
6 |
Material Type: Article
|
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular DiseaseThe New England journal of medicine, 2022-11, Vol.387 (20), p.1855-1864 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2211023 ;PMID: 36342163Full text available |
|
7 |
Material Type: Article
|
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysisThe Lancet (British edition), 2010-10, Vol.376 (9749), p.1312-1319 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 16-Oct 22, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61273-1 ;PMID: 20801494 ;CODEN: LANCAOFull text available |
|
8 |
Material Type: Article
|
The China Acute Myocardial Infarction (CAMI) Registry: A National Long-term Registry-Research-Education Integrated Platform for Exploring Acute Myocardial Infarction in ChinaThe American heart journal, 2016-05, Vol.175, p.193-201.e3 [Peer Reviewed Journal]2015 The Authors ;Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 2016 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2015.04.014 ;PMID: 27179740 ;CODEN: AHJOA2Full text available |
|
9 |
Material Type: Article
|
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial InfarctionJournal of the American College of Cardiology, 2015-05, Vol.65 (20), p.2211-2221 [Peer Reviewed Journal]American College of Cardiology Foundation ;2015 American College of Cardiology Foundation ;Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 26, 2015 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.03.003 ;PMID: 25787199Full text available |
|
10 |
Material Type: Article
|
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trialThe Lancet (British edition), 2009-02, Vol.373 (9665), p.723-731 [Peer Reviewed Journal]Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Feb 28-Mar 6, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)60441-4 ;PMID: 19249633 ;CODEN: LANCAOFull text available |
|
11 |
Material Type: Article
|
Platelet functions beyond hemostasisJournal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1759-1766 [Peer Reviewed Journal]2009 International Society on Thrombosis and Haemostasis ;ISSN: 1538-7933 ;ISSN: 1538-7836 ;EISSN: 1538-7836 ;DOI: 10.1111/j.1538-7836.2009.03586.x ;PMID: 19691483Full text available |
|
12 |
Material Type: Article
|
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 TrialThe American heart journal, 2018-06, Vol.200, p.83-89 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 2018 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2018.01.012 ;PMID: 29898853Full text available |
|
13 |
Material Type: Article
|
Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 StudyDiabetes care, 2020-02, Vol.43 (2), p.468-475 [Peer Reviewed Journal]2019 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-1476 ;PMID: 31843945Full text available |
|
14 |
Material Type: Article
|
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formationThe American heart journal, 2007, Vol.153 (1), p.66.e9-66.e16 [Peer Reviewed Journal]2007 ;Copyright Elsevier Limited Jan 2007 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2006.10.010 ;PMID: 17174640 ;CODEN: AHJOA2Full text available |
|
15 |
Material Type: Article
|
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLECirculation (New York, N.Y.), 2023-04, Vol.147 (16), p.1192-1203 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circulationaha.122.063399 ;PMID: 36779348Full text available |
|
16 |
Material Type: Article
|
DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial InfarctionJournal of the American College of Cardiology, 2016-05, Vol.67 (21), p.2492-2502 [Peer Reviewed Journal]American College of Cardiology Foundation ;2016 American College of Cardiology Foundation ;Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 31, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.03.485 ;PMID: 27046159Full text available |
|
17 |
Material Type: Article
|
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trialsThe Lancet (British edition), 2009-09, Vol.374 (9694), p.989-997 [Peer Reviewed Journal]Elsevier Ltd ;2009 Elsevier Ltd ;Copyright Elsevier Limited Sep 19-Sep 25, 2009 ;Copyright Elsevier Limited Sep 19, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61525-7 ;PMID: 19726078 ;CODEN: LANCAOFull text available |
|
18 |
Material Type: Article
|
Response by Kato et al to Letter Regarding Article, “Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus”Circulation (New York, N.Y.), 2019-10, Vol.140 (18), p.e740-e741 [Peer Reviewed Journal]2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.042848 ;PMID: 31657959Full text available |
|
19 |
Material Type: Article
|
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trialEuropean heart journal, 2009-07, Vol.30 (14), p.1753-1763 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org 2009 ;2009 INIST-CNRS ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehp159 ;PMID: 19435740Full text available |
|
20 |
Material Type: Article
|
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trialThe Lancet (British edition), 2008-04, Vol.371 (9621), p.1353-1363 [Peer Reviewed Journal]Elsevier Ltd ;2008 Elsevier Ltd ;Copyright Elsevier Limited Apr 19-Apr 25, 2008 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)60422-5 ;PMID: 18377975 ;CODEN: LANCAOFull text available |